Weight loss program for patients who had pre-eclampsia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to help overweight and obese patients who have experienced pre-eclampsia to reduce their body mass index (BMI) without losing lean body mass. Participants will choose between two dietary approaches: a hypocaloric diet or a dissociated diet, both of which have been minimally studied in the context of post-pre-eclampsia management. The study focuses on nutritional management tailored to individual preferences, with the goal of addressing the link between pre-eclampsia, obesity, and chronic kidney disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Person affiliated to social security
* Free, informed and written consent signed by the participant and the investigator (no later than the day of day of inclusion and before any examination required by the research)
* Patient over 18 years of age at the time of inclusion and \< 45 years of age
* Having had an pre-eclampsia in the last 5 years according to the definitions of the ISSHP 2018
* Patient with a BMI between 25 kg/m² and 40 kg/m² who accepts dietetic follow up
* Patient with a medical prescription for dietetic follow-up aimed at losing weight loss
* Patient with a balanced diet

Exclusion Criteria:

* Patients with a mental disability or language barrier that prevents them from understanding or consenting to the study
* Patients deprived of their liberty by judicial or administrative decision
* Patients under psychiatric care
* Patients subject to a legal protection measure
* Patients with cognitive disorders or defined eating disorders
* Patients who are pregnant or breast-feeding
* Patients undergoing steroid treatment and/or immunosuppression
* Have been on a low-calorie or dissociated diet for at least 6 months
* Patients with CKD stage ≥ 3A

Where it's running

• Centre Hospitalier Du Mans
  Le Mans, France Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pre-eclampsia risk in pregnancies after oocyte donation

  We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.

  Recruiting at 6 sites Copenhagen University Hospital, Hvidovre · Copenhagen and 5 other locations · NCT07263490

• Use of metformin to prolong pregnancy in preterm preeclampsia in the Netherlands

  In pregnant people with preterm preeclampsia, this study tests whether metformin can help them stay pregnant longer compared with placebo.

  Recruiting Phase 3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06452498

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.